Novo Integrated Sciences Inc (NASDAQ:NVOS) price closed higher on Monday, November 20, jumping 2.60% above its previous close.
A look at the daily price movement shows that the last close reads $1.54, with intraday deals fluctuated between $1.47 and $1.615. The company’s 5Y monthly beta was ticking -0.25. Taking into account the 52-week price action we note that the stock hit a 52-week high of $5.38 and 52-week low of $0.69. The stock subtracted -44.54% on its value in the past month.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give NVOS a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that NVOS’s price is at present -27.30% off the SMA20 and -43.63% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 39.60, with weekly volatility standing at 10.92%. The indicator jumps to 26.93% when calculated based on the past 30 days. Novo Integrated Sciences Inc (NASDAQ:NVOS)’s beta value is holding at -0.40, while the average true range (ATR) indicator is currently reading 0.45.
An analysis of the Novo Integrated Sciences Inc (NASDAQ:NVOS) stock in terms of its daily trading volume indicates that the 3-month average is 5.48 million. However, this figure increases on the past 10-day timeline to an average of 5.01 million.
Current records show that the company has 16.81M in outstanding shares. The insiders’ percentage holdings are 7.73% of outstanding shares while the percentage share held by institutions stands at 3.87%. The stats also highlight that short interest as of Oct 30, 2023, stood at 1.39 million shares, which puts the short ratio at the time at 0.51. From this we can glean that short interest is 8.27% of company’s current outstanding shares. Notably, we see that shares short in October rose slightly given the previous month’s figure stood at 0.54 million. But the -21.43% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.